Transcatheter arterial chemoembolization for liver cancer: is it time to distinguish conventional from drug-eluting chemoembolization?
about
Postoperative adjuvant transarterial (chemo)embolisation after liver resection for hepatocellular carcinomaDevelopment and novel therapeutics in hepatocellular carcinoma: a reviewTransarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and futureInterventional therapies for hepatocellular carcinomaLocoregional drug delivery using image-guided intra-arterial drug eluting bead therapyImaging Biomarkers of Tumor Response in Neuroendocrine Liver Metastases Treated with Transarterial Chemoembolization: Can Enhancing Tumor Burden of the Whole Liver Help Predict Patient Survival?The efficacy of TACE combined sorafenib in advanced stages hepatocellullar carcinoma.Uveal Melanoma Metastatic to the Liver: The Role of Quantitative Volumetric Contrast-Enhanced MR Imaging in the Assessment of Early Tumor Response after Transarterial Chemoembolization.Radiologic-pathologic analysis of contrast-enhanced and diffusion-weighted MR imaging in patients with HCC after TACE: diagnostic accuracy of 3D quantitative image analysisVolumetric assessment of tumour response using functional MR imaging in patients with hepatocellular carcinoma treated with a combination of doxorubicin-eluting beads and sorafenib.Identifying Staging Markers for Hepatocellular Carcinoma before Transarterial Chemoembolization: Comparison of Three-dimensional Quantitative versus Non-three-dimensional Imaging MarkersSynthesis and characterization of image-able polyvinyl alcohol microspheres for image-guided chemoembolization.Delayed-Phase Cone-Beam CT Improves Detectability of Intrahepatic Cholangiocarcinoma During Conventional Transarterial Chemoembolization.Radiopaque drug-eluting beads for transcatheter embolotherapy: experimental study of drug penetration and coverage in swine.Transcatheter intraarterial therapies: rationale and overviewA new angiographic imaging platform reduces radiation exposure for patients with liver cancer treated with transarterial chemoembolizationFeasibility of a Modified Cone-Beam CT Rotation Trajectory to Improve Liver Periphery Visualization during Transarterial Chemoembolization.DC BeadM1™: towards an optimal transcatheter hepatic tumour therapy.Image-guided thermal therapy with a dual-contrast magnetic nanoparticle formulation: A feasibility studyImproved Visibility of Metastatic Disease in the Liver During Intra-Arterial Therapy Using Delayed Arterial Phase Cone-Beam CT.Chemoembolization and radioembolization for hepatocellular carcinoma.Renal Cell Carcinoma Metastatic to the Liver: Early Response Assessment after Intraarterial Therapy Using 3D Quantitative Tumor Enhancement Analysis.Efficacy of TACE in TIPS patients: comparison of treatment response to chemoembolization for hepatocellular carcinoma in patients with and without a transjugular intrahepatic portosystemic shunt.Transcatheter treatment of hepatocellular carcinoma with Doxorubicin-loaded DC Bead (DEBDOX): technical recommendationsQuality-improvement guidelines for hepatic transarterial chemoembolization.Transarterial chemoembolization of hepatocellular carcinoma--agents and drugs: an overview. Part 2.Intra-arterial therapy of neuroendocrine tumour liver metastases: comparing conventional TACE, drug-eluting beads TACE and yttrium-90 radioembolisation as treatment options using a propensity score analysis model.Transcatheter arterial embolization in normal canine liver.Interventional Oncology in Hepatocellular Carcinoma: Progress Through Innovation.Multifunctional microbeads for drug delivery in TACE.Prognosis of cerebral lipiodol embolism caused by transarterial chemoembolization.Should we routinely use DEBTACE for unresectable HCC? cTACE versus DEBTACE: a single-center survival analysis.Conventional vs drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma.Toxicity of doxorubicin on pig liver after chemoembolization with doxorubicin-loaded microspheres: a pilot DNA-microarrays and histology study.Which Criteria Applied in Multi-Phasic CT Can Predict Early Tumor Response in Patients with Hepatocellular Carcinoma Treated Using Conventional TACE: RECIST, mRECIST, EASL or qEASL?Transarterial Chemoembolization for the Treatment of Advanced-Stage Hepatocellular Carcinoma.Characterization of a novel intrinsically radiopaque Drug-eluting Bead for image-guided therapy: DC Bead LUMI™.Preventative effects of prostaglandin E1 in combination with iodized olive oil on liver fibrosis after transcatheter arterial chemoembolization in a rabbit model of CCl4-induced liver fibrosis.Quantitative portal vein velocity of liver cancer patients with transcatheter arterial chemoembolization on angiography
P2860
Q24202070-1C4F34A9-1095-4830-8D64-8C4BA5A2F8F3Q26752854-797999DE-FFF0-48F2-9463-329E948828F0Q26771776-0E8B70FD-643B-4949-8C68-9DFAF93B0025Q26864803-00E56ABD-C70B-4E4C-B6D5-08EB9F7F68C2Q27015918-5C2127CA-8ED0-488A-9010-475B71FE9B10Q33658301-9DFC692C-F51A-48A5-A0C4-FB0AE4DC0A95Q34312854-4117DE1B-DD17-4A53-B584-2F7FA00D80E6Q34369283-2FDADDA8-636B-4033-8CAA-6BBC6B0490D2Q34680081-E288A3EF-A2BD-4E57-AA95-A738532E4E73Q35073497-C562C9FF-D259-433E-A4E7-A436F1DCAEBFQ35537007-7A9BBF71-5E53-4CB2-88A4-137C79E7F290Q35672442-E5F66C7A-6D45-4987-BBF8-A1A3A231479DQ35689195-BF7C8062-789E-468A-BF2B-6529C0073DA1Q35988578-D3A1FFEA-C1A8-4CE8-9386-79EDF42FF946Q36104314-D8B914F5-A7DE-4A99-BF83-C3A1AC1D6874Q36128106-FE0DC237-539D-4DF0-9F8C-6C81DA1887A8Q36303733-CC0BD06B-3672-4D3C-94B7-2A6031271F6BQ36378569-80EF959C-CD52-492F-8493-CBEC4B2ED25DQ37075313-ECEEC2F1-F2EE-4F5A-AE1E-9763A75C23E4Q37227499-0359399D-C10F-49BD-9B21-BBB30A7D7516Q37238192-EB694E29-4D9C-4951-98D4-0042EE39FC47Q37253841-924F39E3-F390-4CB1-B780-BAEDB8B12420Q37408313-1901EFE3-642A-4C9B-8C61-74062D709003Q37947148-80637B6F-B8BA-42F1-BA3A-DF70310AB02EQ38014773-5C676E04-7029-469C-96BC-A2DA72A4546CQ38107281-00F13FA4-944C-4CB6-9037-99B9ECB2DA07Q38693622-D301A5A5-DE07-4900-A949-D0E16BFE47CFQ38756986-31E5F683-6975-4BF1-897D-5782BF5A016EQ38792625-8D8563EE-C5AE-49BC-B7CC-A309D84B0801Q38843998-D18598D7-3221-43D4-8822-106422E15752Q38881017-DF741B5E-0EAC-4C42-812A-B1CFEB60CD18Q39015625-4D449D5C-F6FF-4050-A427-85B1283D1991Q39434012-C6E281B4-3B9C-4658-AA89-1D3E1A43DECFQ44131322-674EB968-F5E1-436D-9993-04573BA41FC1Q50223119-D9A43001-FD1E-4773-8CB8-16C0268EA7B2Q50323331-8C5B3EB8-D326-45AF-AFE3-067F350C8C57Q51008694-1FE314F7-4DC5-4A22-B5B8-BF92080EBA05Q53523427-9E35C851-832A-4518-B438-191C95F76060Q58915077-2735C2D5-FC6F-4C15-A040-81DF3CCF6C2A
P2860
Transcatheter arterial chemoembolization for liver cancer: is it time to distinguish conventional from drug-eluting chemoembolization?
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Transcatheter arterial chemoem ...... rug-eluting chemoembolization?
@en
Transcatheter arterial chemoem ...... rug-eluting chemoembolization?
@nl
type
label
Transcatheter arterial chemoem ...... rug-eluting chemoembolization?
@en
Transcatheter arterial chemoem ...... rug-eluting chemoembolization?
@nl
prefLabel
Transcatheter arterial chemoem ...... rug-eluting chemoembolization?
@en
Transcatheter arterial chemoem ...... rug-eluting chemoembolization?
@nl
P2860
P1476
Transcatheter arterial chemoem ...... rug-eluting chemoembolization?
@en
P2093
Jean-Francois H Geschwind
P2860
P2888
P356
10.1007/S00270-010-0012-Y
P50
P577
2010-11-12T00:00:00Z